Related references
Note: Only part of the references are listed.Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
Seth J. Rotz et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Ana Martin Garcia et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2021)
Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors
Giana Berleze Penna et al.
SUPPORTIVE CARE IN CANCER (2021)
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
Guilherme H. Oliveira et al.
BONE MARROW TRANSPLANTATION (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus
Jakob R. Passweg et al.
BONE MARROW TRANSPLANTATION (2020)
Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat
Julie Kay Baker et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology*
Massimo F. Piepoli et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety
Alexander R. Lyon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Opportunities for improved cardiovascular disease prevention in oncology patients
Katia Bravo-Jaimes et al.
CURRENT OPINION IN CARDIOLOGY (2020)
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Jelena Celutkiene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology
Radek Pudil et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Strain Imaging in Cardio-Oncology
Jennifer E. Liu et al.
JACC: CARDIOONCOLOGY (2020)
Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach
Luisa Giaccone et al.
JOURNAL OF BLOOD MEDICINE (2020)
Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Rafael F. Duarte et al.
BONE MARROW TRANSPLANTATION (2019)
Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation
Robin M. Brusen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Role of physical therapy pre and post hematopoietic stem cell transplantation – White paper report
Jaleel Mohammed et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Cardiotoxicity of mediastinal radiotherapy
Ivica Ratosa et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2019)
Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis
Jessica M. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation
Shawn C. Pun et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2018)
Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction
Kathleen W. Zhang et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient
Juan Carlos Plana et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Prediction of cardiovascular disease among hematopoietic cell transplantation survivors
Saro H. Armenian et al.
BLOOD ADVANCES (2018)
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT
Z. DeFilipp et al.
BONE MARROW TRANSPLANTATION (2017)
Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process
Ioannis A. Paraskevaidis et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
Teresa Lopez-Fernandez et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors
Saro H. Armenian et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The metabolic syndrome and its components in pediatric survivors of allogeneic hematopoietic stem cell transplantation
Bella Bielorai et al.
CLINICAL TRANSPLANTATION (2017)
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions
Pankaj Mathur et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training
Jessica M. Scott et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantation
Avichai Shimoni et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
KARDIOLOGIA POLSKA (2016)
Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology
Sadeer G. Al-Kindi et al.
MAYO CLINIC PROCEEDINGS (2016)
Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis
Julien Ternacle et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Marie Therese Rubio et al.
HAEMATOLOGICA (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Marie Therese Rubio et al.
HAEMATOLOGICA (2015)
Late Cardiovascular Complications after Hematopoietic Cell Transplantation
Eric J. Chow et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Cardiovascular Disease in Survivors of Hematopoietic Cell Transplantation
Saro H. Armenian et al.
CANCER (2014)
Influence of Conventional Cardiovascular Risk Factors and Lifestyle Characteristics on Cardiovascular Disease After Hematopoietic Cell Transplantation
Eric J. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
Joerg Herrmann et al.
MAYO CLINIC PROCEEDINGS (2014)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Prevalence of Hematopoietic Cell Transplant Survivors in the United States
Navneet S. Majhail et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Reproducibility of Echocardiographic Techniques for Sequential Assessment of Left Ventricular Ejection Fraction and Volumes Application to Patients Undergoing Cancer Chemotherapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management
Sumandeep Dhesi et al.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2013)
Hyperlipidemia and Statin Use after Allogeneic Hematopoietic Stem Cell Transplantation
Bradley W. Blaser et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
Saro H. Armenian et al.
BLOOD (2012)
Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation
Eric J. Chow et al.
ANNALS OF INTERNAL MEDICINE (2011)
Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
Victor Feliz et al.
CLINICAL CARDIOLOGY (2011)
Long-Term Consequences of Hematopoietic Stem Cell Transplantation: Current State of the Science
K. Scott Baker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Predictors of Late Cardiovascular Complications in Survivors of Hematopoietic Cell Transplantation
Saro H. Armenian et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management
Michelle L. Griffith et al.
BLOOD (2010)
Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation
E. Peres et al.
BONE MARROW TRANSPLANTATION (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation
Andre Tichelli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Cardiovascular disease after hematopoietic cell transplantation - lessons learned
Saro H. Armenian et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Late Congestive Heart Failure After Hematopoietic Cell Transplantation
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
Smita Bhatia et al.
BLOOD (2007)
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation
Andre Tichelli et al.
BLOOD (2007)
Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: Fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan
A. Shimoni et al.
LEUKEMIA (2007)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Cardiac manifestations of graft-versus-host disease
C Rackley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study
S Bhatia et al.
BLOOD (2005)
Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction
K Fujimaki et al.
BONE MARROW TRANSPLANTATION (2001)
Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide
JA Snowden et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
